Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Sundhedsagenturet ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8%   Bankruptcy risk   4.5% 5.5% 7.1% 5.4% 3.5% 9.2% 18.4% 18.1%   Credit score (0-100)   48 42 34 40 53 26 8 8   Credit rating   BBB BBB BBB BBB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   181 323 293 289 201 74.6 0.0 0.0   EBITDA   15.8 29.2 14.3 288 201 74.6 0.0 0.0   EBIT   15.8 29.2 14.3 288 201 74.6 0.0 0.0   Pre-tax profit (PTP)   15.0 31.2 16.6 283.2 311.7 45.1 0.0 0.0   Net earnings   10.7 24.4 -22.2 217.0 238.9 31.7 0.0 0.0   Pre-tax profit without non-rec. items   15.0 31.2 16.6 283 312 45.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   126 150 128 345 584 116 65.6 65.6   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 33.9 0.0 0.0   Balance sheet total (assets)   197 199 191 468 677 193 65.6 65.6   Net Debt   -51.3 -70.3 -191 -431 -675 -159 -65.6 -65.6     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   181 323 293 289 201 74.6 0.0 0.0   Gross profit growth   73.4% 79.1% -9.3% -1.4% -30.5% -62.9% -100.0% 0.0%   Employees   2 2 1 0 0 1 0 0   Employee growth %   0.0% 0.0% -50.0% -100.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   197 199 191 468 677 193 66 66   Balance sheet change%   22.4% 0.9% -4.0% 144.8% 44.9% -71.5% -66.0% 0.0%   Added value   15.8 29.2 14.3 287.9 200.9 74.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.7% 9.0% 4.9% 99.6% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.8% 15.8% 9.0% 87.4% 54.7% 17.2% 0.0% 0.0%   ROI %   13.1% 22.7% 12.6% 121.8% 67.5% 20.5% 0.0% 0.0%   ROE %   8.9% 17.7% -16.0% 91.8% 51.5% 9.1% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   63.8% 75.5% 67.0% 73.8% 86.2% 59.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -325.3% -241.0% -1,335.2% -149.5% -336.3% -213.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 29.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   580.1% 0.0% 0.0% 0.0% 0.0% 176.5% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   2.9 4.5 3.0 3.8 27.3 2.6 0.0 0.0   Current Ratio   2.9 4.5 3.0 3.8 27.3 2.6 0.0 0.0   Cash and cash equivalent   51.3 70.3 191.0 430.5 675.4 192.8 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   130.0 155.0 127.9 344.9 113.5 117.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   8 15 14 0 0 75 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   8 15 14 0 0 75 0 0   EBIT / employee   8 15 14 0 0 75 0 0   Net earnings / employee   5 12 -22 0 0 32 0 0